EFFECT OF COMBINATION TREATMENT WITH CYCLOPHOSPHAMIDE AND ISOGENEIC OR ALLOGENEIC SPLEEN AND BONE MARROW CELLS IN LEUKEMIC (L1210) MICE

被引:42
作者
VADLAMUDI, S
PADARATHSINGH, M
BONMASSAR, E
GOLDIN, A
机构
关键词
D O I
10.1002/ijc.2910070118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:160 / +
页数:1
相关论文
共 16 条
[1]  
ALEXANDE.P, 1966, CANCER RES, V26, P1508
[2]  
BALME R H, 1962, Minn Med, V45, P892
[3]  
BATCHELOR JR, 1960, TRANSPLAN B, V26, P449
[4]  
Eckhardt S, 1965, Antimicrob Agents Chemother (Bethesda), V5, P503
[5]  
FEFER A, 1969, CANCER RES, V29, P2177
[6]  
FREI EMIL, 1965, ADVANCE CHEMOTHERAP, V2, P269
[7]  
GLYNN JP, 1969, CANCER RES, V29, P515
[8]  
GLYNN JP, 1963, CANCER RES, V23, P1008
[9]   IMMUNITY OF MICE SURVIVING SYSTEMIC LEUKAEMIA (L1210) TO ANTIFOLIC RESISTANT VARIANTS OF THE DISEASE [J].
GOLDIN, A ;
HUMPHREYS, SR ;
CHAPMAN, GO ;
CHIRIGOS, MA ;
VENDITTI, JM .
NATURE, 1960, 185 (4708) :219-221
[10]  
GOLDIN A, 1960, J NATL CANCER I, V24, P283